Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex

被引:36
作者
Kontkanen, O
Lakso, M
Wong, G
Castrén, E
机构
[1] Univ Kuopio, AI Virtanen Inst, FIN-70211 Kuopio, Finland
[2] Univ Kuopio, Dept Psychiat, FIN-70211 Kuopio, Finland
关键词
schizophrenia; clozapine; haloperidol; transcription factors; in situ hybridization;
D O I
10.1016/S0893-133X(02)00289-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have characterized the effects of chronic clozapine and haloperidol treatments on the expression of fos (c-fos, fosB, fra-2) and jun (c-jun, junB, junD) family genes in the rat forebrain. The effects of chronic (17d) clozapine and haloperidol on mRNA expression were determined two hours, 24 hours, and six days after the last drug injection, and the DNA-binding activity of the activator protein-1 (AP-1) complex was studied a er washout periods of 24 hours and six days. Chronic clozapine treatment with a 6 d washout period induced the expression of several fos and jun family genes in cortical regions, including the prefrontal cortex (PFC), and in the caudate putamen and nucleus accumbens. Moreover, the DNA-binding activity of the AP-1 complex was greatly increased in the anterior cingulate cortex-PFC in mobility shift assays already after 24 h, and remained increased after a 6 d washout period. Chronic administration of haloperidol upregulated fos and jun family mRNA expression that was detectable 24 h and 6 d after cessation of the treatment mainly in the cortex. However, the DNA-binding activity of the AP-1 complex was not altered in the anterior cingulate cortex-PFC by chronic haloperidol administration at any of the time points studied. Thus, chronic treatments with clozapine and haloperidol induce a long-lasting enhancement of fos and jun family transcription factors that continues for several days after the cessation of the treatments in the cortex. These lasting effects might represent events that are potentially involved in the mechanisms of antipsychotic drug action.
引用
收藏
页码:152 / 162
页数:11
相关论文
共 38 条
[1]  
Atkins JB, 1999, SYNAPSE, V33, P118, DOI 10.1002/(SICI)1098-2396(199908)33:2<118::AID-SYN2>3.3.CO
[2]  
2-C
[3]   TISSUE CONCENTRATIONS OF CLOZAPINE AND ITS METABOLITES IN THE RAT [J].
BALDESSARINI, RJ ;
CENTORRINO, F ;
FLOOD, JG ;
VOLPICELLI, SA ;
HUSTONLYONS, D ;
COHEN, BM .
NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) :117-124
[4]   Long-term expression of the 35,000 mol wt fos-related antigen in rat brain after kainic acid treatment [J].
Bing, G ;
McMillian, M ;
Kim, H ;
Pennypacker, K ;
Feng, Z ;
Qi, Q ;
Kong, LY ;
Iadarola, M ;
Hong, JS .
NEUROSCIENCE, 1996, 73 (04) :1159-1174
[5]   LINEAR PHARMACOKINETICS OF HALOPERIDOL IN THE RAT [J].
CHENG, YF ;
PAALZOW, LK .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1992, 13 (01) :69-76
[6]   DIFFERENCES BETWEEN ANTIPSYCHOTIC-DRUGS IN PERSISTENCE OF BRAIN LEVELS AND BEHAVIORAL-EFFECTS [J].
COHEN, BM ;
TSUNEIZUMI, T ;
BALDESSARINI, RJ ;
CAMPBELL, A ;
BABB, SM .
PSYCHOPHARMACOLOGY, 1992, 108 (03) :338-344
[7]   The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization [J].
Deutch, AY ;
Duman, RS .
NEUROSCIENCE, 1996, 70 (02) :377-389
[8]   Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of Delta FosB-like protein(s) in both the rodent and primate striatum [J].
Doucet, JP ;
Nakabeppu, Y ;
Bedard, PJ ;
Hope, BT ;
Nestler, EJ ;
Jasmin, BJ ;
Chen, JS ;
Iadarola, MJ ;
StJean, M ;
Wigle, N ;
Blanchet, P ;
Grondin, R ;
Robertson, GS .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (02) :365-381
[9]   THE USE OF C-FOS AS A METABOLIC MARKER IN NEURONAL PATHWAY TRACING [J].
DRAGUNOW, M ;
FAULL, R .
JOURNAL OF NEUROSCIENCE METHODS, 1989, 29 (03) :261-265
[10]   D2 DOPAMINE RECEPTOR ANTAGONISTS INDUCE FOS AND RELATED PROTEINS IN RAT STRIATAL NEURONS [J].
DRAGUNOW, M ;
ROBERTSON, GS ;
FAULL, RLM ;
ROBERTSON, HA ;
JANSEN, K .
NEUROSCIENCE, 1990, 37 (02) :287-294